Literature DB >> 21419799

Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction.

Jinjong Myoung1, Don Ganem.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is the etiological agent of Kaposi's sarcoma (KS) and at least two B cell lymphoproliferative diseases: primary effusion lymphoma (PEL) and multicentric Castleman's disease (MCD). B cells derived from PEL are latently infected, and can be induced to lytic replication by treatment with chemical agents like TPA or butyrate, which have pleiotropic effects on host cell signaling and chromatin structure. Most of these lines also display moderate levels of spontaneous lytic induction, which complicates analysis of latency. Here we describe the creation of latently infected cell lines derived from SLK endothelial cells that (i) display tight control of KSHV latency, with little spontaneous reactivation and (ii) are efficiently inducible by doxycycline, avoiding the need for pleiotropic inducing agents. These cells produce substantial quantities of infectious KSHV, and should be useful for studies of the latent-lytic switch and the impact of lytic replication on host cell biology.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21419799      PMCID: PMC3095772          DOI: 10.1016/j.jviromet.2011.03.012

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  33 in total

1.  Transcriptional regulation of the Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor gene.

Authors:  J Chen; K Ueda; S Sakakibara; T Okuno; K Yamanishi
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Activation of latent Kaposi's sarcoma-associated herpesvirus by demethylation of the promoter of the lytic transactivator.

Authors:  J Chen; K Ueda; S Sakakibara; T Okuno; C Parravicini; M Corbellino; K Yamanishi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

3.  The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway.

Authors:  Yuying Liang; Jean Chang; Stephen J Lynch; David M Lukac; Don Ganem
Journal:  Genes Dev       Date:  2002-08-01       Impact factor: 11.361

4.  DNA binding by Kaposi's sarcoma-associated herpesvirus lytic switch protein is necessary for transcriptional activation of two viral delayed early promoters.

Authors:  D M Lukac; L Garibyan; J R Kirshner; D Palmeri; D Ganem
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  Infection of primary human tonsillar lymphoid cells by KSHV reveals frequent but abortive infection of T cells.

Authors:  Jinjong Myoung; Don Ganem
Journal:  Virology       Date:  2011-02-25       Impact factor: 3.616

6.  Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus.

Authors:  J Vieira; P O'Hearn; L Kimball; B Chandran; L Corey
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

7.  Transcription activation of polyadenylated nuclear rna by rta in human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus.

Authors:  M J Song; H J Brown; T T Wu; R Sun
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

8.  Rta of the human herpesvirus 8/Kaposi sarcoma-associated herpesvirus up-regulates human interleukin-6 gene expression.

Authors:  Hongyu Deng; Julia T Chu; Matthew B Rettig; Otoniel Martinez-Maza; Ren Sun
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

9.  Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator.

Authors:  Hiroyuki Nakamura; Michael Lu; Yousang Gwack; John Souvlis; Steven L Zeichner; Jae U Jung
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

10.  Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SCID-hu Thy/Liv mice.

Authors:  D Dittmer; C Stoddart; R Renne; V Linquist-Stepps; M E Moreno; C Bare; J M McCune; D Ganem
Journal:  J Exp Med       Date:  1999-12-20       Impact factor: 14.307

View more
  183 in total

1.  The ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma–associated herpesvirus.

Authors:  Alexander S Hahn; Johanna K Kaufmann; Effi Wies; Elisabeth Naschberger; Julia Panteleev-Ivlev; Katharina Schmidt; Angela Holzer; Martin Schmidt; Jin Chen; Simone König; Armin Ensser; Jinjong Myoung; Norbert H Brockmeyer; Michael Stürzl; Bernhard Fleckenstein; Frank Neipel
Journal:  Nat Med       Date:  2012-06       Impact factor: 53.440

2.  Kaposi's Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor 1 Interacts with a Member of the Interferon-Stimulated Gene 15 Pathway.

Authors:  Sarah R Jacobs; Charles M Stopford; John A West; Christopher L Bennett; Louise Giffin; Blossom Damania
Journal:  J Virol       Date:  2015-09-09       Impact factor: 5.103

3.  Kaposi's sarcoma-associated herpesvirus K7 modulates Rubicon-mediated inhibition of autophagosome maturation.

Authors:  Qiming Liang; Brian Chang; Kevin F Brulois; Kamilah Castro; Chan-Ki Min; Mary A Rodgers; Mude Shi; Jianning Ge; Pinghui Feng; Byung-Ha Oh; Jae U Jung
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

4.  The cellular peptidyl-prolyl cis/trans isomerase Pin1 regulates reactivation of Kaposi's sarcoma-associated herpesvirus from latency.

Authors:  Jonathan Guito; Aileen Gavina; Diana Palmeri; David M Lukac
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

5.  The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 To Facilitate Establishment of Latency.

Authors:  Xiaoxi Lin; Rui Sun; Fang Zhang; Yuan Gao; Lianghua Bin; Ke Lan
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

6.  Viral FGARAT Homolog ORF75 of Rhesus Monkey Rhadinovirus Effects Proteasomal Degradation of the ND10 Components SP100 and PML.

Authors:  Alexander S Hahn; Anna K Großkopf; Doris Jungnickl; Brigitte Scholz; Armin Ensser
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

7.  Virus-Like Vesicles of Kaposi's Sarcoma-Associated Herpesvirus Activate Lytic Replication by Triggering Differentiation Signaling.

Authors:  Danyang Gong; Xinghong Dai; Yuchen Xiao; Yushen Du; Travis J Chapa; Jeffrey R Johnson; Xinmin Li; Nevan J Krogan; Hongyu Deng; Ting-Ting Wu; Ren Sun
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

8.  LL-37 disrupts the Kaposi's sarcoma-associated herpesvirus envelope and inhibits infection in oral epithelial cells.

Authors:  David C Brice; Zsolt Toth; Gill Diamond
Journal:  Antiviral Res       Date:  2018-08-02       Impact factor: 5.970

9.  The FAT10 post-translational modification is involved in the lytic replication of Kaposi's sarcoma-associated herpesvirus.

Authors:  Atsuko Sugimoto; Yuichi Abe; Tadashi Watanabe; Kohei Hosokawa; Jun Adachi; Takeshi Tomonaga; Yasumasa Iwatani; Takayuki Murata; Masahiro Fujimuro
Journal:  J Virol       Date:  2021-02-24       Impact factor: 5.103

Review 10.  An Epigenetic Journey: Epstein-Barr Virus Transcribes Chromatinized and Subsequently Unchromatinized Templates during Its Lytic Cycle.

Authors:  Adityarup Chakravorty; Bill Sugden; Eric C Johannsen
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.